A detailed history of Jane Street Group, LLC transactions in Io Biotech, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 23,717 shares of IOBT stock, worth $36,761. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,717
Previous 23,717 -0.0%
Holding current value
$36,761
Previous $25,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$0.79 - $1.2 $18,736 - $28,460
23,717 New
23,717 $25,000
Q2 2022

Aug 16, 2022

SELL
$3.79 - $8.38 $54,121 - $119,666
-14,280 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$3.73 - $8.74 $53,264 - $124,807
14,280 New
14,280 $76,000

Others Institutions Holding IOBT

About IO Biotech, Inc.


  • Ticker IOBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,815,300
  • Market Cap $44.7M
  • Description
  • IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...
More about IOBT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.